Research programme: cardiovascular disorders therapy - Medicago

Drug Profile

Research programme: cardiovascular disorders therapy - Medicago

Alternative Names: Cardiovascular vaccine - Acambis/Medicago; MED-201; MED-202; MED-205

Latest Information Update: 15 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medicago
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cardiovascular disorders; Hypercholesterolaemia

Most Recent Events

  • 17 Jul 2006 Preclinical trials in Hypercholesterolaemia in Canada (PO)
  • 17 Jul 2006 A preclinical study has been added to the Lipid Disorders pharmacodynamics section
  • 02 Aug 2005 Preclinical trials in Cardiovascular disorders in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top